GT Biopharma Inc
(GTBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | EVGN | DRMA | ||
| Company | GT Biopharma Inc | Evogene Ltd Ord | Dermata Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.5100 | 1.0500 | 1.9100 | ||
| High | 0.5203 | 1.1600 | 1.9200 | ||
| Low | 0.4800 | 1.0400 | 1.7320 | ||
| Latest | 0.4965 | 1.1000 | 1.7700 | ||
| Change | -0.0304 | +0.0100 | -0.1600 | ||
| % Change | -5.77% | +0.92% | -8.29% | ||
| Volume | 900,700 | 580,900 | 269,700 | ||
| 20-Day Average Volume | 1,880,980 | 695,905 | 1,869,580 | ||
| Previous Close | 0.5269 | 1.0900 | 1.9300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.6661 | 1.0531 | 2.2270 | ||
| 20-Day Raw Stochastic | 25.18% | 46.13% | 1.30% | ||
| 20-Day Relative Strength | 36.21 | 53.23 | 42.29 | ||
| Weighted Alpha | -83.32 | -25.19 | -86.61 | ||
| Today's Opinion | 88% Sell | 72% Sell | 96% Sell | ||
| Previous Opinion | 88% Sell | 72% Sell | 96% Sell | ||
| Last Month's Opinion | 24% Sell | 64% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -26.99% since 01/29/26 | +8.91% since 01/29/26 | -37.01% since 01/29/26 | ||
| Low | 0.4011 on 02/02/26 | 0.9801 on 02/04/26 | 1.7320 on 02/05/26 | ||
| High | 0.7012 on 01/30/26 | 1.2400 on 02/04/26 | 2.8500 on 01/30/26 | ||
| 1-Month | |||||
| %Chg | -37.94% since 01/05/26 | -1.79% since 01/05/26 | -19.55% since 01/05/26 | ||
| Low | 0.4011 on 02/02/26 | 0.9801 on 02/04/26 | 1.7320 on 02/05/26 | ||
| High | 0.8062 on 01/06/26 | 1.2400 on 02/04/26 | 4.6600 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | -18.65% since 11/05/25 | -6.78% since 11/05/25 | -44.16% since 11/05/25 | ||
| Low | 0.4011 on 02/02/26 | 0.9300 on 12/30/25 | 1.5800 on 12/29/25 | ||
| High | 1.1500 on 11/14/25 | 1.2800 on 11/12/25 | 4.6600 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | -71.95% since 08/05/25 | -18.52% since 08/05/25 | -74.68% since 08/05/25 | ||
| Low | 0.4011 on 02/02/26 | 0.9300 on 12/30/25 | 1.5800 on 12/29/25 | ||
| High | 1.8900 on 08/08/25 | 1.5000 on 10/08/25 | 6.9900 on 08/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,604 | 5,848 | 5,472 | ||
| Shares Outstanding, K | 10,636 | 5,365 | 2,835 | ||
| Annual Sales | 0 | 8,510,000 | 0 | ||
| Annual Net Income | -13,160,000 | -16,490,000 | -12,290,000 | ||
| Last Quarter Sales | 0 | 310,000 | 0 | ||
| Last Quarter Net Income | -3,110,000 | 3,870,000 | -1,690,000 | ||
| 60-Month Beta | 1.21 | 1.35 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 11/14/25 | -0.31 on 11/20/25 | -1.65 on 11/14/25 | ||
| Latest Earnings Date | 02/20/26 | 03/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||